The key Omega 3 fatty acid components are EPA and DHA, which have clinically proven health benefits for a number of health conditions. Our Incromega™ range of fish oil concentrates include high EPA and DHA oils, supporting our customers’ brands to focus on these health areas.
Product finderView our product portfolio
Incromega products are manufactured at our dedicated facility in the UK using our PureMax™ purification technology and the benefit of over 30 years’ experience to provide our customers and their brands with quality assurance at every step in the supply chain. Investment in Good Manufacturing Practices (GMPs) and lipid research and development ensures we continue to deliver exceptional Omega 3 fish oil concentrates for nutritional applications.
Health conditionsDiscover our Incromega fish oils that can help to achieve therapeutic benefits for a variety of health conditions:
- Pregnancy & new mums
Lifestyle & wellbeingWe provide tailored Omega 3 product solutions to support consumer health and wellbeing during specific life stages:
- Kids & Teens
Clinical studiesWe are active in the support of clinical studies around the world to further develop knowledge of the health benefits of Incromega oils. We work with a large number of research institutes to support the evaluation of Incromega fish oil concentrates across all areas of health and wellness, including cardiovascular health, pregnancy, rheumatoid arthritis, cholesterol and cancers. The amount of clinical work based on Incromega oils provides strong scientific assurance of their health benefits.
Incromega - Pure and Essential brochure
Quality and sustainability
Incromega fish oil concentrates are produced using PureMax technology, which both selectively concentrates EPA and/or DHA while stripping out environmental contaminants. Our proprietary PureMax process encompasses multiple refining steps and quality checks and we test every single Incromega batch against all specification parameters to provide 100% confidence to our customers.
Our Purpose, Smart science to improve lives™ is at the core of our Human and Veterinary market strategy.Learn more
Looking for information on our products and technologies? Please take a moment and register with us, so that you can quickly access product datasheets and performance data, formulations, videos, webinars and Material Safety Data Sheets.View resources
The development of oral drugs presents several challenges, including low solubility, instability of the formulation and ineffective delivery of the IFA. The selection of the correct oral excipient during the initial stage of development is a critical step in achieving the success of the formulation.Learn more